There is limited knowledge about the incidence of IDH1 and IDH2 mutations in acute lymphoid leukemia (ALL) patients and the prevalence of these mutations in acute leukemia patients in Saudi Arabia. This evidence concerns the gene IDH1 and acute lymphoblastic leukemia.